Slashdot Mirror
Startup Tests Drugs Aimed at Autism
An anonymous reader sends in this link from Technology Review about a startup company testing drugs that may help those with autism-spectrum disorders — even adults. "Seaside Therapeutics, a startup based in Cambridge, MA, is testing two compounds for the treatment of fragile X syndrome, a rare, inherited form of intellectual disability linked to autism. The treatments have emerged from molecular studies of animal models that mirror the genetic mutations seen in humans. Researchers hope that the drugs, which are designed to correct abnormalities at the connections between neurons, will ultimately prove effective in other forms of autism spectrum disorders. ... The company is funded almost entirely by an undisclosed family investment of $60 million, with $6 million from the National Institutes of Health. [A spokesman] says that Seaside has enough funding to take its compounds through clinical testing and approval."
yawn. is this supposed to be sarcasm? wrong forum, buddy. don't feed the trolls kids. it's what they want you to do.
Beware the Jubjub bird, and shun the frumious Bandersnatch.
I never claimed that the drug was not targeted for fragile X, in fact only you mentioned the drug and autism in the same sentence. Perhaps you should reread the OP.
Never extrapolated as I never claimed that it worked on adult humans or that they even tested it on humans at all. Only that they claimed that it worked on the animals that they tested. Nice try at back peddling though.